Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Comment on "KB004, a first in class monoclonal antibody targeting the receptor tyrosine kinase EphA3, in patients with advanced hematologic malignancies: Results from a phase 1 study".
Leuk Res. 2017 Apr;55:55-57. doi: 10.1016/j.leukres.2017.01.009. Epub 2017 Jan 9.
Leuk Res. 2017.
PMID: 28129558
No abstract available.
CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors.
Hughes A, Clarson J, Tang C, Vidovic L, White DL, Hughes TP, Yong AS.
Hughes A, et al. Among authors: clarson j.
Blood. 2017 Mar 2;129(9):1166-1176. doi: 10.1182/blood-2016-10-745992. Epub 2017 Jan 3.
Blood. 2017.
PMID: 28049640
Free article.
Item in Clipboard
Successful treatment-free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells.
Irani YD, Hughes A, Clarson J, Kok CH, Shanmuganathan N, White DL, Yeung DT, Ross DM, Hughes TP, Yong ASM.
Irani YD, et al. Among authors: clarson j.
Br J Haematol. 2020 Nov;191(3):433-441. doi: 10.1111/bjh.16718. Epub 2020 Apr 30.
Br J Haematol. 2020.
PMID: 32352166
Free article.
Item in Clipboard
Demethylating therapy increases anti-CD123 CAR T cell cytotoxicity against acute myeloid leukemia.
El Khawanky N, Hughes A, Yu W, Myburgh R, Matschulla T, Taromi S, Aumann K, Clarson J, Vinnakota JM, Shoumariyeh K, Miething C, Lopez AF, Brown MP, Duyster J, Hein L, Manz MG, Hughes TP, White DL, Yong ASM, Zeiser R.
El Khawanky N, et al. Among authors: clarson j.
Nat Commun. 2021 Nov 8;12(1):6436. doi: 10.1038/s41467-021-26683-0.
Nat Commun. 2021.
PMID: 34750374
Free PMC article.
Item in Clipboard
Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemia.
Ross DM, Pagani IS, Irani YD, Clarson J, Leclercq T, Dang P, McLean J, Saunders VA, Carne L, Reynolds J, Ritchie DS, White DL, Branford S, Hughes TP, Yong ASM.
Ross DM, et al. Among authors: clarson j.
Br J Haematol. 2019 Aug;186(3):e56-e60. doi: 10.1111/bjh.15894. Epub 2019 Mar 27.
Br J Haematol. 2019.
PMID: 30916385
Free article.
Clinical Trial.
No abstract available.
Item in Clipboard
Immune modulation in chronic myeloid leukaemia patients treated with nilotinib and interferon-alpha.
Irani YD, Hughes A, Kok CH, Clarson J, Yeung DT, Ross DM, Branford S, Hughes TP, Yong ASM.
Irani YD, et al. Among authors: clarson j.
Br J Haematol. 2023 Sep;202(6):1127-1136. doi: 10.1111/bjh.18984. Epub 2023 Jul 22.
Br J Haematol. 2023.
PMID: 37482935
Item in Clipboard
Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia.
Irani YD, Kok CH, Clarson J, Shanmuganathan N, Branford S, Yeung DT, Ross DM, Hughes TP, Yong ASM.
Irani YD, et al. Among authors: clarson j.
Blood Adv. 2023 Jun 13;7(11):2364-2374. doi: 10.1182/bloodadvances.2022008854.
Blood Adv. 2023.
PMID: 36622326
Free PMC article.
Item in Clipboard
Cite
Cite